Kestra Medical Technologies, Ltd. Insider Trading

KMTS

Last 12 months

Insiders bought 200K and sold $15.4M on the open market.

69% of the selling was scheduled in advance under 10b5-1 plans. See Remarks Brian Daniel Webster sold $1.27M on Aug 4, 9.8% of their stake, outside a plan.

Net open-market

−$15.2M

1 buy · 30 sales

Under a 10b5-1 plan

69%

of the value sold

Insiders who bought / sold

1 / 11

executives and directors

Last open-market buy

Mar 2026

Mar 26, 2026

Get an email when KMTS's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Oct 27 – 29	Vaseem Mahboob Chief Financial Officer	Sold10b5-1 plan 3 parts	79,500	$30.30 average	$2.41M	57%	Form 4
Oct 27	Traci S Umberger See Remarks	Sold10b5-1 plan	30,000	$30.03	901K	13%	Form 4
Oct 21	Traci S Umberger See Remarks	Sold10b5-1 plan 2 parts	100,000	$27.18 average	$2.72M	34%	Form 4
Oct 20	Brian Daniel Webster See Remarks	Sold10b5-1 plan 2 parts	15,000	$29.56 average	443K	3.3%	Form 4
Sep 30	Raymond W Cohen Director	SoldNo plan	3,330	$29.28	98K	5.7%	Form 4
Sep 21	Elizabeth Kwo Director	SoldNo plan	4,010	$24.26	97K	22%	Form 4
Sep 8	Conor Hanley Director	SoldNo plan	5,694	$25.25	144K	30%	Form 4
Sep 8	Kevin C Reilly Director	SoldNo plan	2,932	$25.13	74K	19%	Form 4
Sep 8	Mary Kay Ladone Director	SoldNo plan	3,908	$25.20	98K	8.0%	Form 4
Sep 8	Jeffrey Lawrence Schwartz Director	SoldNo plan	3,890	$25.18	98K	<0.1%	Form 4
Aug 17	Brian Daniel Webster See Remarks	Sold10b5-1 plan	15,000	$27.48	412K	3.2%	Form 4
Aug 7	Vaseem Mahboob Chief Financial Officer	Sold10b5-1 plan 2 parts	26,287	$25.88 average	680K	30%	Form 4
Aug 4	Alfred J Ford Jr Chief Commercial Officer	SoldNo plan	6,275	$24.09	151K	5.9%	Form 4
Aug 4	Vaseem Mahboob Chief Financial Officer	Sold10b5-1 plan 2 parts	6,995	$24.68 average	173K	7.5%	Form 4
Aug 4	Traci S Umberger See Remarks	SoldNo plan	3,580	$24.04	86K	1.8%	Form 4
Aug 4	Brian Daniel Webster See Remarks	SoldNo plan 3 parts	51,900	$24.52 average	$1.27M	9.8%	Form 4
Jul 30 – Aug 3	Timothy P. Moran Chief Business Officer	SoldNo plan 3 parts	15,256	$22.83 average	348K	19%	Form 4
Jul 30 – Aug 3	Alfred J Ford Jr Chief Commercial Officer	SoldNo plan 3 parts	27,632	$23.25 average	642K	21%	Form 4
Jul 30 – Aug 3	Vaseem Mahboob Chief Financial Officer	SoldNo plan 3 parts	18,188	$22.99 average	418K	16%	Form 4
Jul 30 – Aug 3	Traci S Umberger See Remarks	SoldNo plan 3 parts	22,229	$23.07 average	513K	10%	Form 4
Jul 30 – Aug 3	Brian Daniel Webster See Remarks	SoldNo plan 3 parts	29,822	$23.21 average	692K	5.4%	Form 4
Jul 15	Brian Daniel Webster See Remarks	Sold10b5-1 plan 3 parts	15,000	$22.44 average	337K	2.6%	Form 4
Jun 15	Brian Daniel Webster See Remarks	Sold10b5-1 plan	15,000	$20.81	312K	3.7%	Form 4
May 15	Brian Daniel Webster See Remarks	Sold10b5-1 plan 2 parts	15,000	$20.95 average	314K	4.3%	Form 4
Apr 15	Brian Daniel Webster See Remarks	Sold10b5-1 plan	15,000	$20.04	301K	4.1%	Form 4
Mar 26	Raymond W Cohen Director	Bought	10,000	$19.98	200K	24%	Form 4
Mar 17	Brian Daniel Webster See Remarks	Sold10b5-1 plan	15,000	$20.27	304K	3.9%	Form 4
Feb 17	Brian Daniel Webster See Remarks	Sold10b5-1 plan 3 parts	15,000	$25.60 average	384K	3.8%	Form 4
Jan 15	Brian Daniel Webster See Remarks	Sold10b5-1 plan	15,000	$22.80	342K	3.7%	Form 4
Dec 29, 2025	Traci S Umberger See Remarks	Sold10b5-1 plan	10,500	$26.69	280K	7.1%	Form 4
Dec 29, 2025	Brian Daniel Webster See Remarks	Sold10b5-1 plan	15,000	$26.59	399K	3.5%	Form 4
Mar 7, 2025	Alfred J Ford Jr Chief Commercial Officer	Bought	20,000	$17.00	340K	68%	Form 4
Mar 7, 2025	Traci S Umberger See Remarks	Bought	13,500	$17.00	230K	11%	Form 4
Mar 7, 2025	Raymond W Cohen Director	Bought	17,000	$17.00	289K	71%	Form 4

Oct 27 – 2910b5-1 plan
Vaseem Mahboob
Chief Financial Officer · sold 79,500 at avg $30.30
$2.41M
57% of stake
Oct 2710b5-1 plan
Traci S Umberger
See Remarks · sold 30,000 at $30.03
901K
13% of stake
Oct 2110b5-1 plan
Traci S Umberger
See Remarks · sold 100,000 at avg $27.18
$2.72M
34% of stake
Oct 2010b5-1 plan
Brian Daniel Webster
See Remarks · sold 15,000 at avg $29.56
443K
3.3% of stake
Sep 30No plan
Raymond W Cohen
Director · sold 3,330 at $29.28
98K
5.7% of stake
Sep 21No plan
Elizabeth Kwo
Director · sold 4,010 at $24.26
97K
22% of stake
Sep 8No plan
Conor Hanley
Director · sold 5,694 at $25.25
144K
30% of stake
Sep 8No plan
Kevin C Reilly
Director · sold 2,932 at $25.13
74K
19% of stake
Sep 8No plan
Mary Kay Ladone
Director · sold 3,908 at $25.20
98K
8.0% of stake
Sep 8No plan
Jeffrey Lawrence Schwartz
Director · sold 3,890 at $25.18
98K
<0.1% of stake
Aug 1710b5-1 plan
Brian Daniel Webster
See Remarks · sold 15,000 at $27.48
412K
3.2% of stake
Aug 710b5-1 plan
Vaseem Mahboob
Chief Financial Officer · sold 26,287 at avg $25.88
680K
30% of stake
Aug 4No plan
Alfred J Ford Jr
Chief Commercial Officer · sold 6,275 at $24.09
151K
5.9% of stake
Aug 410b5-1 plan
Vaseem Mahboob
Chief Financial Officer · sold 6,995 at avg $24.68
173K
7.5% of stake
Aug 4No plan
Traci S Umberger
See Remarks · sold 3,580 at $24.04
86K
1.8% of stake
Aug 4No plan
Brian Daniel Webster
See Remarks · sold 51,900 at avg $24.52
$1.27M
9.8% of stake
Jul 30 – Aug 3No plan
Timothy P. Moran
Chief Business Officer · sold 15,256 at avg $22.83
348K
19% of stake
Jul 30 – Aug 3No plan
Alfred J Ford Jr
Chief Commercial Officer · sold 27,632 at avg $23.25
642K
21% of stake
Jul 30 – Aug 3No plan
Vaseem Mahboob
Chief Financial Officer · sold 18,188 at avg $22.99
418K
16% of stake
Jul 30 – Aug 3No plan
Traci S Umberger
See Remarks · sold 22,229 at avg $23.07
513K
10% of stake
Jul 30 – Aug 3No plan
Brian Daniel Webster
See Remarks · sold 29,822 at avg $23.21
692K
5.4% of stake
Jul 1510b5-1 plan
Brian Daniel Webster
See Remarks · sold 15,000 at avg $22.44
337K
2.6% of stake
Jun 1510b5-1 plan
Brian Daniel Webster
See Remarks · sold 15,000 at $20.81
312K
3.7% of stake
May 1510b5-1 plan
Brian Daniel Webster
See Remarks · sold 15,000 at avg $20.95
314K
4.3% of stake
Apr 1510b5-1 plan
Brian Daniel Webster
See Remarks · sold 15,000 at $20.04
301K
4.1% of stake
Mar 26
Raymond W Cohen
Director · bought 10,000 at $19.98
200K
24% of stake
Mar 1710b5-1 plan
Brian Daniel Webster
See Remarks · sold 15,000 at $20.27
304K
3.9% of stake
Feb 1710b5-1 plan
Brian Daniel Webster
See Remarks · sold 15,000 at avg $25.60
384K
3.8% of stake
Jan 1510b5-1 plan
Brian Daniel Webster
See Remarks · sold 15,000 at $22.80
342K
3.7% of stake
Dec 29, 202510b5-1 plan
Traci S Umberger
See Remarks · sold 10,500 at $26.69
280K
7.1% of stake
Dec 29, 202510b5-1 plan
Brian Daniel Webster
See Remarks · sold 15,000 at $26.59
399K
3.5% of stake
Mar 7, 2025
Alfred J Ford Jr
Chief Commercial Officer · bought 20,000 at $17.00
340K
68% of stake
Mar 7, 2025
Traci S Umberger
See Remarks · bought 13,500 at $17.00
230K
11% of stake
Mar 7, 2025
Raymond W Cohen
Director · bought 17,000 at $17.00
289K
71% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch KMTS, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Surgical & Medical Instruments & Apparatus · Pick stocks to compare with KMTS

CompareIntrinsic value

XTNTXtant Medical Holdings Inc.

$0.30+7.14%15

NPCENeuroPace Inc.

$13.34+8.37%30

OSUROrasure Technologies Inc.

$3.72+5.38%20

MHUAFMeihua International Medical Technologies Co., Ltd.

$6.30-8.16%59

BBNXBeta Bionics Inc.

$16.95+12.25%40

ANIKAnika Therapeutics Inc.

$20.40+4.88%35

DCTHDelcath Systems Inc.

$14.82+2.92%62

LUNGPulmonx Corporation

$2.83+4.04%30

Held by ETFs

KMTS is in 24 US ETFs. The largest of them, with KMTS's weight in each:

Spot a number that looks wrong? Check it in KMTS's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing KMTS

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.